Tyme Technologies : Annual Report (Form 10-K)
Tyme-10k_20220331.htm Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | May 25, 2022
Source: marketscreener.com
Jonathan Eckard News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jonathan Eckard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jonathan Eckard Today - Breaking & Trending Today
TYME Technologies, Inc. to Present at H.C. Wainwright Bioconnect Virtual Conference
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business Officer, will present at the H...
Source: pharmiweb.com
TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference
TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced that Richie Cunningham, Chief Executive
Source: finanznachrichten.de